HÀ NỘI — Thái Minh Pharmaceuticals on Sunday officially launched its new brand identity and product packaging while announcing its investment in the US biotechnology company ENZ Biopharma.

This strategic move reflects the group’s vision of 'Pioneering science, Lifelong care,' as it continues to expand its global reach and maintain its commitment to innovation, quality and international standards.

Following 13 years of strong growth and success in Việt Nam’s pharmaceutical market, the new brand identity represents a pivotal transformation. The modern logo and updated packaging symbolise a commitment to consistency, modernisation and customer trust. Inspired by a heart design that combines the ideas of health, love, protection and care, the new design incorporates advanced anti-counterfeit features to ensure authenticity and build consumer confidence. Importantly, while the company has updated its external image, it guarantees that product quality remains unchanged.

This rebrand aligns with Thái Minh’s strategic goals of improving product standards, optimising research and expanding into foreign markets. The company has also recently secured an investment licence for the Việt Nam Ginseng and Medicinal Materials Institute project at Hòa Lạc High-Tech Park in Hà Nội and inaugurated a state-of-the-art cell laboratory equipped for advanced scientific research.

The announcement of its partnership with ENZ Biopharma in the US further cements Thái Minh’s ambition to integrate advanced biotechnology and research into its operations. This partnership will allow the group to access cutting-edge technologies, benefit from advanced research and establish a modern, FDA GMP-certified factory at Hòa Lạc High-Tech Park by 2025.

Chairman of the Board and founder of Thái Minh Pharmaceuticals Group Nguyễn Quang Thái said: "We want to improve quality so that Vietnamese consumers can use products that meet international standards right at home. Cooperating with the US partners is part of that commitment. Thái Minh constantly strives to bring products that are not only good for health but also meet the highest quality standards, building long-term trust in the hearts of Vietnamese consumers."

This bold combination of rebranding, strategic research investments and international partnerships signals Thái Minh’s commitment to innovation, quality, and global growth. The group is positioned to shape the future of pharmaceutical science by combining local expertise with global opportunities, strengthening both its market presence and its promise to consumers. — VNS